April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Retinal Ganglion Cell Response to IOP Reduction Following Glaucoma Surgery
Author Affiliations & Notes
  • M. L. Goodkin
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens, Florida
  • D. S. Grewal
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens, Florida
  • M. Sehi
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens, Florida
  • D. S. Greenfield
    Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Palm Beach Gardens, Florida
  • Footnotes
    Commercial Relationships  M.L. Goodkin, None; D.S. Grewal, None; M. Sehi, None; D.S. Greenfield, Lace Ellectronica, F; Allergan, C.
  • Footnotes
    Support  NIH Grants R01-EY08684, RO1-EY013516; Unrestricted grant from Research to Prevent Blindness P30-EY14801; Unrestricted grant from Allergan Inc.; Research support from Lace Ellectronica
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2237. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. L. Goodkin, D. S. Grewal, M. Sehi, D. S. Greenfield; Retinal Ganglion Cell Response to IOP Reduction Following Glaucoma Surgery. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2237.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The Pattern Electroretinogram (PERG) is a non-invasive method of objectively measuring retinal ganglion cell (RGC) function. Preliminary evidence suggests that PERG may measure reversal of RGC dysfunction in glaucomatous eyes after pharmacologic reduction in intraocular pressure (IOP). This study was undertaken to quantify the RGC response to IOP reduction following glaucoma surgery.

Methods: : Prospective cohort study of patients uncontrolled on maximal medical therapy, or with progression of glaucomatous optic neuropathy. Patients requiring trabeculectomy or aqueous drainage device who met eligibility criteria were recruited. Eyes with visual acuity less than 20/30, ocular disease other than cataract or glaucoma, or unreliable standard automated perimetry (SAP) were excluded. All patients underwent complete ocular examination, blood pressure, IOP, SAP, and PERG before surgery and at 3 months post-surgery. Each measure of PERG was an average of 600 artifact-free signal registrations. Paired samples t-test, Pearson and Spearman correlation coefficients were calculated.

Results: : 40 patients (mean age 69.7±12.8 years) were enrolled. Twenty-nine patients (72.5%) underwent trabeculectomy with antifibrosis therapy; 11 patients (27.5%) underwent glaucoma drainage implant surgery. Mean postoperative IOP (10.5±4.8mmHg) and number of glaucoma medications (0.7±1.1) were significantly (p<0.001) reduced compared to prior to surgery (20.7±8.6mmHg and 3.0±1.1, respectively). Mean postoperative PERG amplitude (0.5±0.2) was significantly (p=0.02) increased compared to mean preoperative PERG amplitude (0.4±0.2). Mean postoperative MOPP (52.9±6.7mmHg) was significantly (p<0.001) increased compared to mean preoperative MOPP (44.4±10.8 mmHg). Mean preoperative PERG phase (1.8±0.2rad), SAP MD (-10.7±7.6 dB), and PSD (7.7±3.8 dB) were unchanged (p=0.2-0.7) following surgery. No correlation (p=0.2-0.8) was identified between change in PERG amplitude and preoperative IOP, MOPP, SAP MD or PSD, age, gender, race, eye, or type of surgery.

Conclusions: : Our data demonstrates that reversal of RGC dysfunction occurs following surgical reduction in IOP and may be quantified using PERG.

Keywords: electrophysiology: clinical • ganglion cells • intraocular pressure 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×